Robert Holloway, MD

Dr Robert Holloway is Medical Director of Gynecologic Oncology at AdventHealth Cancer Institute, Orlando Florida. He is a founding member of AdventHealth Global Robotics Institute and clinical Professor of Ob/Gyn at FSU & UCF Colleges of Medicine. Dr. Holloway lectures regularly at national and international conferences, serves as principal investigator for several clinical trials, and conducts advanced training courses for robotic surgeons.  His research interests include novel therapies for ovarian and uterine cancers, and his clinical program also supports a 3-year academic training fellowship in gynecologic oncology that is recognized for excellence in surgical and medical oncology training.  

Dr Holloway received a BS from U of Illinois-Urbana, medical degree from Vanderbilt University, Ob/Gyn residency at U Alabama Birmingham, and Gyn/Onc Fellowship at Georgetown University, Washington DC in 1990. He is well-published with over 350 scientific abstracts, peer reviewed publications, and book chapters.  He was honored with a degree in Science (DHc) from Pleven Medical University, Pleven Bulgaria in 2015 for his advances in robotic surgery techniques and training. Dr Holloway is currently the national principal investigator for a OnPrime, a phase 3 clinical trial investigating intraperitoneal oncolytic virus therapy in advanced ovarian cancer.